The University of Texas Southwestern Medical Center — Dallas, Texas

Public research footprint of The University of Texas Southwestern Medical Center, compiled from the ClinicalTrials.gov public registry.

157

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Heart Failure With Reduced Ejection Fraction · Von Willebrand Disease (VWD), Type 1 · Spasticity as Sequela of Stroke

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT06793215 — A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus… (Recruiting)
NCT04919122 — Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Texas Southwestern Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.